$TRAX
First Tracks Biotherapeutics, Inc. Ordinary Shares
XNAS•Health Care•Pharmaceutical Preparations
$49.73
▲+7.44%+$3.45Market open
First Tracks Biotherapeutics, Inc. Ordinary Shares
XNAS•Health Care•Pharmaceutical Preparations
Why is TRAX up today? It is at $49.73 (+7.32%), and our scanner flagged it 203 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment TRAX spikes, and full due diligence on TRAX — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $TRAX 203 times in the last 30 days. Create a free account to track $TRAX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
TRAX is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 3 unusual-volume and momentum alerts on TRAX today, peaking at 11.8x its normal volume. Fresh from the SEC: First Tracks Biotherapeutics, Inc.: Q3 FY2026 results, three months to Sep 30, 2026. A material company disclosure like this is often the real catalyst behind a move of this size.
Likely catalystFirst Tracks Biotherapeutics, Inc.: Q3 FY2026 results, three months to Sep 30, 2026, from an SEC filing. Read it →Latest filing4Insider trade (Form 4)Nov 3, 2026 · todayAcross every filing on file, supply equal to 360.6% of the tradeable float is in play - 360.6% has already been sold.
One filing exceeds the whole float, which usually means our share count is stale. Check the filing directly.
Recent priced share offering — a one-time sale that has already completed (not ongoing)
10,497,054 new shares
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Orwin John A Director | Other | 1K | added 7.8% | 18K | n/a | Sep 15, 26 |
Ware J. Anthony Director | Sold (automatic/other) | -39K 0.1% of company | sold 71% | 16K | $1.8M at $44.78 | Sep 2, 26 |
Ware J. Anthony Director | Other | 39K 0.1% of company | added 100% | 55K | $225K at $5.74 | Sep 2, 26 |
Fenton Dennis M Director | Other | 6K 0.02% of company | added 100% | 11K | n/a | Jun 15, 26 |
Orwin John A Director | Other | 6K 0.02% of company | added 57% | 17K | n/a | Jun 15, 26 |
Marquet Magda Director | Other | 6K 0.02% of company | added 61% | 16K | n/a | Jun 15, 26 |
Ware J. Anthony Director | Other | 6K 0.02% of company | added 63% | 16K | n/a | Jun 15, 26 |
Jain Rita Director | Other | 7K 0.02% of company | added 62% | 19K | n/a | Jun 15, 26 |
Schmid John P. Director | Other | 6K 0.02% of company | added 19% | 38K | n/a | Jun 15, 26 |
Anaptysbio, Inc Beneficial Owner (10%) | Sold (automatic/other) | -100 | n/a | n/a | n/a | Apr 20, 26 |
Ecor1 Capital, Llc Beneficial Owner (10%) | Sold (automatic/other) | -4.71M 13.2% of company | sold 60% | 3.17M | $65.0M at $13.81 | Apr 20, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
TRAX is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 3 unusual-volume and momentum alerts on TRAX today, peaking at 11.8x its normal volume. Fresh from the SEC: First Tracks Biotherapeutics, Inc.: Q3 FY2026 results, three months to Sep 30, 2026. A material company disclosure like this is often the real catalyst behind a move of this size.
TRAX last traded at $49.73, up 7.32% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
First Tracks Biotherapeutics, Inc. Ordinary Shares (TRAX) is next expected to report earnings on Wednesday, November 11, 2026, about 7 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The TRAX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged TRAX 203 times in the last 30 days.
TRAX (First Tracks Biotherapeutics, Inc. Ordinary Shares) trades on XNAS, with a market cap of about $1.66B in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge TRAX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$TRAX discussion
Sign in to ask a question or join the discussion.